How malaria parasites exploit mechanism for escaping elimination could provide novel strategies targeting chronic malaria ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic ...

Researchers were able to test how viruses replicate differently across various bat species and organs using the new organoid ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

HHS Secretary Robert F. Kennedy Jr. and biopharmas will negotiate drug prices individually. Kennedy could "propose a ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...